Abstract
Tumor-intrinsic MLL1 drives transcriptional reprogramming in response to EZH2 inhibition.
- ©2018 American Association for Cancer Research.
Log in using your username and password
Purchase Short Term Access
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
November 2018
Volume 8, Issue 11
Volume 8, Issue 11
MLL1-Induced Oncogenic Reprogramming Drives EZH2 Inhibitor Resistance
Jump to section
Advertisement